NCT01125306

Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Meir Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Xal-Ease is a novel Pfizer-Pharmacia device aimed to significantly facilitate the Xalatan/Xalacom instillation and to avoid loss of Xalatan/Xalacom eye drops due to incorrect instillation. Patients on Xalatan/Xalacom who have consumed more than one bottle per month within a year according to consumption data drawn from the Clalit Health Services database, will use the Xal-Ease device for a year. The device is expected to reduce consumption of bottles and result in saving money for both patients and medical care providers.

Conditions

• Glaucoma
• Hypertension

Interventions

Type	Name	Description
DEVICE	Xal-Ease	Xal-Ease device used to facilitate application of Xalatan/Xalacom eye drops.

Timeline

• Start date: 2009-06-01
• Primary completion: 2011-08-01
• Completion: 2012-10-01
• First posted: 2010-05-18
• Last updated: 2012-03-16

Locations

1 site across 1 country: Israel